Next, we determined MS4A1 (CD20), CD74 and IL4R gene expression levels in 84 lymphoma samples across different tumor stages (stage I-III/IV) and compared to expression in 12 healthy tissue controls using quantitative PCR of tissue biopsies. This evidence concerns the gene IL4R and neoplasm.